Please assess the completion status of the following clinical trial:

Trial Title: Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Crohn disease patients with a small intestine localisation (ileum or ileocecal)~2. Ileal or ileocecal resection in the month before inclusion (resection of all macroscopic lesions). If resection with temporary stoma, the patient may be included at the time of surgery to restore the continuity~3. Patient with low risk of recurrence according to the following criteria:~   (i) Total length of the resection(s) of the small intestine less than 100 cm (ii) Segmental colectomy leaving in place at least another colonic segment as the rectum~4. Preoperative rate of ASCA\> 70 arbitrary units (+/- 10%)~5. Informed consent signed to be involved in the study~Exclusion Criteria:~1. Pregnant women or without adequate contraception~2. Total length of the resection(s) of the small intestine more than 1 meter~3. Subtotal colic resection~4. Preoperative rate of ASCA\<63 arbitrary units (+/- 10%)~5. Known hypersensitivity to fluconazole or other azoles~6. Known liver disease or transaminase levels \>1.5 the normal rate~7. Patient with renal failure~8. Inability to read and sign the informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluconazole (Type: EXPERIMENTAL): 200mg per day for 6 months
- Placebo (Type: PLACEBO_COMPARATOR): One capsule per day for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).